| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells
|
Wu, Yanyuan
|
|
2017
|
163 |
3 |
p. 449-460
|
artikel
|
| 2 |
A phase II study of combined ridaforolimus and dalotuzumab compared with exemestane in patients with estrogen receptor-positive breast cancer
|
Baselga, José
|
|
2017
|
163 |
3 |
p. 535-544
|
artikel
|
| 3 |
Aromatase expression in atypical ductal hyperplasia in women
|
Santen, R. J.
|
|
2017
|
163 |
3 |
p. 623-629
|
artikel
|
| 4 |
Background parenchymal enhancement on breast MRI: association with recurrence-free survival in patients with newly diagnosed invasive breast cancer
|
Lim, Yaeji
|
|
2017
|
163 |
3 |
p. 573-586
|
artikel
|
| 5 |
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
|
Krammer, Julia
|
|
2017
|
163 |
3 |
p. 565-571
|
artikel
|
| 6 |
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study
|
Tryfonidis, Konstantinos
|
|
2017
|
163 |
3 |
p. 507-515
|
artikel
|
| 7 |
Chemotherapy-induced irreversible alopecia in early breast cancer patients
|
Kim, Gun Min
|
|
2017
|
163 |
3 |
p. 527-533
|
artikel
|
| 8 |
Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting
|
Matter-Walstra, K.
|
|
2017
|
163 |
3 |
p. 635
|
artikel
|
| 9 |
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience
|
Ciccarese, Mariangela
|
|
2017
|
163 |
3 |
p. 587-594
|
artikel
|
| 10 |
Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)
|
Furlanetto, Jenny
|
|
2017
|
163 |
3 |
p. 495-506
|
artikel
|
| 11 |
Erratum to: ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling
|
Gelsomino, Luca
|
|
2017
|
163 |
3 |
p. 639-640
|
artikel
|
| 12 |
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
|
Dieci, M. V.
|
|
2017
|
163 |
3 |
p. 637
|
artikel
|
| 13 |
Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice
|
Lim, Yu Jin
|
|
2017
|
163 |
3 |
p. 555-563
|
artikel
|
| 14 |
FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer
|
Hamurcu, Zuhal
|
|
2017
|
163 |
3 |
p. 485-493
|
artikel
|
| 15 |
Immunoglobulin-like domain 4-mediated ligand-independent dimerization triggers VEGFR-2 activation in HUVECs and VEGFR2-positive breast cancer cells
|
Zhang, Sheng
|
|
2017
|
163 |
3 |
p. 423-434
|
artikel
|
| 16 |
Is breast compression associated with breast cancer detection and other early performance measures in a population-based breast cancer screening program?
|
Moshina, Nataliia
|
|
2017
|
163 |
3 |
p. 605-613
|
artikel
|
| 17 |
Management of the positive axilla in 2017
|
Avisar, Eli
|
|
2017
|
163 |
3 |
p. 413-415
|
artikel
|
| 18 |
Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression
|
Strekalova, Elena
|
|
2017
|
163 |
3 |
p. 435-447
|
artikel
|
| 19 |
ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells
|
Holcakova, Jitka
|
|
2017
|
163 |
3 |
p. 475-484
|
artikel
|
| 20 |
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)
|
Kawaguchi, H.
|
|
2017
|
163 |
3 |
p. 545-554
|
artikel
|
| 21 |
Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer
|
Muti, Paola
|
|
2017
|
163 |
3 |
p. 631-632
|
artikel
|
| 22 |
Prognosis of pregnancy-associated breast cancer
|
Lee, Guek Eng
|
|
2017
|
163 |
3 |
p. 417-421
|
artikel
|
| 23 |
Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience
|
Jendrian, Svenja
|
|
2017
|
163 |
3 |
p. 517-526
|
artikel
|
| 24 |
Relationship of breast MRI to recurrence rates in patients undergoing breast-conservation treatment
|
Hill, Maureen V.
|
|
2017
|
163 |
3 |
p. 615-622
|
artikel
|
| 25 |
Response
|
Chlebowski, Rowan T.
|
|
2017
|
163 |
3 |
p. 633-634
|
artikel
|
| 26 |
RETRACTED ARTICLE: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells
|
Wu, Yanyuan
|
|
|
163 |
3 |
p. 449-460
|
artikel
|
| 27 |
Self-reported long-term cardiac morbidity in breast cancer patients: a retrospective cohort study in Germany (PASSOS Heart Study)
|
Wollschläger, Daniel
|
|
2017
|
163 |
3 |
p. 595-604
|
artikel
|
| 28 |
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
|
Asaduzzaman, Muhammad
|
|
2017
|
163 |
3 |
p. 461-474
|
artikel
|
Tijdschrift beschrijving